Up-regulation of syntaxin1 in ischemic cortex after permanent focal ischemia in rats

Brain Research

Volumn 1272, Issue , 2009, Pages 52-61

  Cao, Fang ^a   Hata, Ryuji ^a   Zhu, Pengxiang ^a   Niinobe, Michinobu ^b   Sakanaka, Masahiro ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Cerebral ischemia; SNARE; Synaptotagmin

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN 2; SYNAPTOTAGMIN; SYNTAXIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RAT; UPREGULATION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; CALCIUM-BINDING PROTEINS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICROTUBULE-ASSOCIATED PROTEINS; RATS; RATS, INBRED SHR; SYNAPTOTAGMINS; SYNTAXIN 1; UP-REGULATION;

RATTUS;

EID: 67349090337     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.03.047     Document Type: Article

References (36)

1. Autieri M.V., Prystowsky M.B., and Ohlstein E.H. Isolation and characterization of BART-1: a novel balloon angioplasty responsive transcript in rat carotid arteries. DNA. Cell Biol. 15 (1996) 297-304
2. Badr A.E., Yin W., Mychaskiw G., and Zhang J.H. Effect of hyperbaric oxygen on striatal metabolites: a microdialysis study in awake freely moving rats after MCA occlusion. Brain. Res. 916 (2001) 85-90
3. Bai J., Wang C.T., Richards D.A., Jackson M.B., and Chapman E.R. Fusion pore dynamics are regulated by synaptotagmin*t-SNARE interactions. Neuron 41 (2004) 929-942
4. Bittner M.A., Bennett M.K., and Holz R.W. Evidence that syntaxin 1A is involved in storage in the secretory pathway. J. Biol. Chem. 271 (1996) 11214-11221
5. Bommert K., Charlton M.P., DeBello W.M., Chin G.J., Betz H., and Augastine G.L. Inhibition of neurotransmitter release by C2-domain peptides implicates synaptotagmin in exocytosis. Nature 363 (1993) 163-165
6. 2+ sensor for transmitter release at a central synapse. Cell 79 (1994) 717-727
7. Chapman E.R. How does synaptotagmin trigger neurotransmitter release?. Annu. Rev. Biochem. 77 (2008) 615-641
8. Gidday J.M. Cerebral preconditioning and ischaemic tolerance. Nat. Rev., Neurosci. 7 (2006) 437-448
9. Hailer N.P. Immunosuppression after traumatic or ischemic CNS damage: it is neuroprotective and illuminates the role of microglial cells. Prog. Neurobiol. 84 (2008) 211-233
10. Hossmann K.A. Pathophysiology and therapy of experimental stroke. Cell Mol. Neurobiol. 26 (2006) 1055-1081
11. Imai Y., and Kohsaka S. Intracellular signaling in M-CSF-induced microglia activation: role of Iba1. Glia 40 (2002) 164-174
12. Imai Y., Ibata I., Ito D., Ohsawa K., and Kohsaka S. A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem. Biophys. Res. Commun. 224 (1996) 855-862
13. Ito U., Kuroiwa T., Nagasao J., Kawakami E., and Oyanagi K. Temporal profiles of axon terminals, synapses and spines in the ischemic penumbra of the cerebral cortex: ultrastructure of neuronal remodeling. Stroke 37 (2006) 2134-2139
14. Kirino T., Tamura A., and Sano K. Chronic maintenance of presynaptic terminals in gliotic hippocampus following ischemia. Brain Res. 510 (1990) 17-25
15. 2+ sensor for neurotransmitter release. Trends Neurosci. 26 (2003) 413-422
16. Lam P.P., Leung Y.M., Sheu L., Ellis J., Tsushima R.G., Osborne L.R., and Gaisano H.Y. Transgenic mouse overexpressing syntaxin-1A as a diabetes model. Diabetes 54 (2005) 2744-2754
17. 2+-activated neurotransmitter release. Cell 74 (1993) 1125-1134
18. 2+-triggered fusion and recycling of synaptic vesicles in vivo. J. Neurosci. 21 (2001) 1421-1433
19. Matsumoto H., Kumon Y., Watanabe H., Ohnishi T., Shudou M., Ii C., Takahashi H., Imai Y., and Tanaka J. Antibodies to CD11b, CD68, and lectin label neutrophils rather than microglia in traumatic and ischemic brain lesions. J. Neurosci. Res. 85 (2007) 994-1009
20. Misonou H., Thompson S.M., and Cai X. Dynamic regulation of the Kv2.1 voltage-gated potassium channel during brain ischemia through neuroglial interaction. J. Neurosci. 28 (2008) 8529-8538
21. Montecucco C., Schiavo G., and Pantano S. SNARE complexes and neuroexocytosis: how many, how close?. Trends Biochem. Sci. 30 (2005) 367-372
22. Morioka T., Kalehua A.N., and Streit W.J. The microglial reaction in the rat dorsal hippocampus following transient forebrain ischemia. J. Cereb. Blood Flow Metab. 11 (1991) 966-973
23. Nellgard B., and Wieloch T. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia. J. Cereb. Blood Flow Metab. 12 (1992) 2-11
24. Nonet M.L., Grundahl K., Meyer B.J., and Rand J.B. Synaptic function is impaired but not eliminated in C. elegans mutants lacking synaptotagmin. Cell 73 (1993) 1291-1305
25. Ogawa S., Kitao Y., and Hori O. Ischemia-induced neuronal cell death and stress response. Antioxid. Redox. Signal. 9 (2007) 573-587
26. Pal S., Hartnett K.A., Nerbonne J.M., Levitan E.S., and Aizenman E. Mediation of neuronal apoptosis by Kv2.1-encoded potassium channels. J. Neurosci. 23 (2003) 4798-4802
27. + channels. Cell Death Differ. 13 (2006) 661-667
28. Schilling M., Besselmann M., Muller M., Strecker J.K., Ringelstein E.B., and Kiefer R. Predominant phagocytic activity of resident microglia over hematogenous macrophages following transient focal cerebral ischemia: an investigation using green fluorescent protein transgenic bone marrow chimeric mice. Exp. Neurol. 196 (2005) 290-297
29. Sheardown M.J., Nielsen E.O., Hansen A.J., Jacobsen P., and Honore T. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science 247 (1990) 571-574
30. Sheardown M.J., Suzdak P.D., and Nordholm L. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h. Eur. J. Pharmacol. 236 (1993) 347-353
31. 2+-regulated exocytosis and SNARE function. Trends Endocrinol. Metab. 16 (2005) 81-83
32. Tanaka F., Ozawa Y., Inage Y., Deguchi K., Itoh M., Imai Y., Kohsaka S., and Takashima S. Association of osteopontin with ischemic axonal death in periventricular leukomalacia. Acta Neuropathol. 100 (2000) 69-74
33. Teng F.Y., Wang Y., and Tang B.L. The syntaxins. Genome Biol. 2 (2001) 24
34. Farr T.D., Carswell H.V.V., and Gallagher L. 17β-Estradiol treatment following permanent focal ischemia does not influence recovery of sensorimotor function. Neurobiol. Dis. 23 3 (2006) 552-562
35. Utans U., Arceci R.J., Yamashita Y., and Russell M.E. Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection. J. Clin. Invest. 95 (1995) 2954-2962
36. Zhang B., Hata R., Zhu P., Sato K., Wen T.C., Yang L., Fujita H., Mitsuda N., Tanaka J., Samukawa K., Maeda N., and Sakanaka M. Prevention of ischemic neuronal death by intravenous infusion of a ginseng saponin, ginsenoside Rb(1), that upregulates Bcl-x(L) expression. J. Cereb. Blood Flow Metab. 26 (2006) 708-721